1. Home
  2. CTXR vs DLPN Comparison

CTXR vs DLPN Comparison

Compare CTXR & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.78

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

N/A

Current Price

$1.54

Market Cap

19.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
CTXR
DLPN
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
19.1M
IPO Year
2010
2008

Fundamental Metrics

Financial Performance
Metric
CTXR
DLPN
Price
$0.78
$1.54
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
555.0K
8.0K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
43.38
77.87
EPS
N/A
N/A
Revenue
N/A
$56,699,389.00
Revenue This Year
N/A
$14.73
Revenue Next Year
$147.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.70
52 Week Low
$0.63
$0.88
52 Week High
$2.38
$1.88

Technical Indicators

Market Signals
Indicator
CTXR
DLPN
Relative Strength Index (RSI) 49.07 46.08
Support Level $0.68 $1.46
Resistance Level $0.99 $1.70
Average True Range (ATR) 0.07 0.07
MACD 0.01 -0.00
Stochastic Oscillator 44.65 42.50

Price Performance

Historical Comparison
CTXR
DLPN

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: